← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Locus Pharmaceuticals, Inc.
Blue Bell, PA
$1,703,923
Total funding
5
Grants
Funding over time
peak $549.5K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,703,923 · 5
By mechanism
R44$926,107 · 1
R43$777,816 · 4
Investigators at Locus Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Optimization of HIV-1 Entry Inhibitors Targeting gp41$549,540
R44 · FY2006 · AI
Optimization of HIV-1 Entry Inhibitors Targeting gp41$376,567
R44 · FY2005 · AI
AMPK as a Target for Cancer Therapy$262,001
R43 · FY2008 · CA
Identification of Novel, Drug-like Inhibitors of Hsp90$235,600
R43 · FY2007 · CA
The Design and Synthesis of Potent GP-41 Inhibitors$180,215
R43 · FY2004 · GM
Optimization of HIV-1 Entry Inhibitors targeting gp41$100,000
R43 · FY2004 · AI